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We detected and mapped a dynamically spreading wave of gray matter loss in the brains of patients with Alzheimer’s disease (AD). The
loss pattern was visualized in four dimensions as it spread over time from temporal and limbic cortices into frontal and occipital brain
regions, sparing sensorimotor cortices. The shifting deficits were asymmetric (left hemisphere right hemisphere) and correlated with
progressively declining cognitive status ( p 0.0006). Novel brain mapping methods allowed us to visualize dynamic patterns of atrophy
in 52 high-resolution magnetic resonance image scans of 12 patients with AD (age 68.4 1.9 years) and 14 elderly matched controls (age
71.4 0.9 years) scanned longitudinally (two scans; interscan interval 2.1 0.4 years). A cortical pattern matching technique encoded
changes in brain shape and tissue distribution across subjects and time. Cortical atrophy occurred in a well defined sequence as the
disease progressed, mirroring the sequence of neurofibrillary tangle accumulation observed in cross sections at autopsy. Advancing
deficits were visualized as dynamic maps that change over time. Frontal regions, spared early in the disease, showed pervasive deficits
later (15% loss). The maps distinguished different phases of AD and differentiated AD from normal aging. Local gray matter loss rates
(5.3 2.3% per year in AD v 0.9 0.9% per year in controls) were faster in the left hemisphere ( p 0.029) than the right. Transient
barriers to disease progression appeared at limbic/frontal boundaries. This degenerative sequence, observed in vivo as it developed,
provides the first quantitative, dynamic visualization of cortical atrophic rates in normal elderly populations and in those with dementia.
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Introduction
Strategies to chart how Alzheimer’s disease (AD) spreads dynam-
ically in the brain are vital for understanding how it progresses
and for mapping treatment effects. A dynamic map of AD could
uncover the path of degeneration for different brain systems and
define a powerful biological marker for clinical trials. Such brain
maps would visualize the order in which cortical systems are
affected in living populations and identify how changes correlate
with cognitive decline.
This study used serial brain imaging and cortical mapping to
visualize how AD spreads spatially and temporally in the brain. It
reveals anatomically selective, stage-specific deficits. It also allows
us to visualize the sequence in which deficits appear. It also pro-
vides the first detailed, three-dimensional (3D) quantitative
maps of cortical gray matter and whole brain changes over time in
any disease.
In early AD, intraneuronal filamentous deposits, or neurofi-
brillary tangles (NFTs), accumulate within neurons. These de-
posits are composed of hyperphosphorylated tau-protein (Hul-
staert et al., 1999). This cellular pathology disrupts axonal
transport and induces widespread metabolic decline. The result-
ing neuronal loss is observable as gross atrophy with magnetic
resonance imaging (MRI). Temporoparietal association cortices
and the medial temporal lobe are severely atrophied in AD (De-
Carli, 2000), with the entorhinal cortex and hippocampus the
earliest and most severely affected (Janke et al., 2001; Thompson
et al., 2001b). Profound atrophy is also observed in the posterior
cingulate gyrus and adjacent precuneus. Specific atrophic pat-
terns differentiate AD from frontotemporal, semantic, and Lewy
body dementias (O’Brien et al., 2001; Studholme et al., 2001).
Patients with AD show minimal primary visual, sensorimotor,
and frontal atrophy until late in the disease. Before symptom
onset in AD, and also in those at genetic risk, gray matter loss is
detectable in the anterior hippocampal/amygdala region (Lehto-
virta et al., 2000; Reiman et al., 2001).
Of particular interest is the temporal sequence of deficits in
AD because they spread across the cortex. Braak and Braak (1997)
noted at autopsy that NFT distribution was initially restricted to
entorhinal cortices, spreading to higher-order temporoparietal
association cortices, then to frontal, and ultimately, to primary
sensory and visual areas (Delacourte et al., 1999; Price and Mor-
ris, 1999).
We set out to determine whether a similar wave of cortical
atrophy could be mapped in patients while they were alive. The
goal was to visualize the transit of the disease within cortex and
relate it to cognitive decline. Recently, we used dynamic brain
mapping to uncover the trajectory of cortical change as schizo-
phrenia develops in the teenage brain (Thompson et al., 2001d)
and as normal adolescents lose gray matter (Sowell et al., 2001).
In dementia, we expected a similarly selective profile of brain
changes, instead emerging from temporal cortices and sparing
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primary cortices until late in the disease. We also hypothesized
first that frontal and association cortices would be progressively
enveloped as cognitive function declined, and second, that the
pathology would evolve differently in each brain hemisphere,
with the left hemisphere engulfed earlier and more severely than
the right.
Materials and Methods
Subjects
Over a time interval of 3 years, we used longitudinal MRI scanning (two
scans, baseline, and follow-up) and cognitive testing to study a group of
subjects with AD as their disease progressed. A second, demographically
matched group of healthy, elderly control subjects was also imaged lon-
gitudinally (two scans) as they aged. The AD subject group consisted of
12 patients who were scanned twice (six men, six women; mean age SE
at first scan 68.4 1.9 years; at final scan, 69.8 2.0 years; mean interval
between first and last scans, 1.5  0.3 years). These patients were diag-
nosed with AD using criteria listed in the Diagnostic and Statistical Man-
ual of Mental Disorders (American Psychiatric Association, 2000), and
they had a typical clinical presentation. They also fulfilled the standards
for probable AD according to criteria established by the National Insti-
tute of Neurological Disorders and Stroke and the Alzheimer’s Disease
and Related Disorders Association (McKhann et al., 1984). All patients
were reassessed at intervals of 3– 6 months with a full clinical evaluation,
and their cognitive status was evaluated using the Mini-Mental State
Exam (MMSE) (Folstein et al., 1975). During the study, subjects’ cogni-
tive status declined rapidly from an initial MMSE score of 17.7 1.9 to
12.9 2.5 (mean change 5.5 1.9 points; p 0.00054, one-tailed t test;
maximum score 30). This corresponds approximately to a transition
from moderate to severe AD. At the same time, a group of 14 healthy
elderly controls was scanned twice (seven men, seven women; age at first
scan 71.4  0.9 years; age at final scan 74.0  0.9 years; mean interval
between first and last scans 2.6 0.3 years). During the study, the control
subjects’ cognitive status remained stable. Their MMSE score was 29.5
0.3 at both baseline and follow-up, with no change.
Exclusion criteria for the two groups included the presence of white
matter lesions on T2-weighted MRI scans, preexisting psychiatric illness
or head injury, and history of substance abuse or depression as measured
by the Geriatric Depression Scale (Yesavage, 1988). All subjects were
right-handed. Informed consent was obtained from all participants be-
fore scanning. AD and control samples consisted of subjects who were
entirely different from the group of patients with AD and controls from
whom data were reported in our previous cross-sectional study (Thomp-
son et al., 2001b). Three disease stages were effectively mapped in this
new, longitudinal sample. These broadly correspond to healthy aging
and the transition from moderate to severe AD (with MMSE scores of 29,
18, and 13, respectively).
MRI scanning
Patients and controls were scanned identically with the same scanning
protocol over time. Each subject underwent two MRI scans separated by
1 year. Images were acquired on a 2 Tesla Bruker Medspec S200 whole-
body scanner (Bruker Medical, Ettingen, Germany) at the Centre for
Magnetic Resonance (University of Queensland, Australia). A linearly
polarized birdcage head-coil (Bruker Medical) was used for signal recep-
tion. Three-dimensional T1-weighted images were acquired with an in-
version recovery segmented 3D gradient echo sequence (known as mag-
netization prepared rapid gradient echo; MP-RAGE) to resolve anatomy
at high resolution. Acquisition parameters were as follows: inversion
time (TI)/repetition time (TR)/echo time (TE) 850/1000/8.3 msec; flip
angle 20°; 32 phase-encoding steps per segment; a 23 cm field of view.
Images were acquired in an oblique plane perpendicular to the long axis
of the hippocampus (Jack et al., 1998), with an acquisition matrix of
256 256 96, and zero-filled to 256 3.
Image processing and analysis
Serial images acquired across the 2 year time span were processed as
follows. Briefly, for each scan, a radio frequency bias field correction
algorithm eliminated intensity drifts attributable to scanner field inho-
mogeneity, using a histogram spline sharpening method (Sled et al.,
1998). Images were then normalized by transforming them to a standard
3D stereotaxic space in a two-step process that retained information on
brain change over time. First, each initial T1-weighted scan was aligned
linearly (registered) to a standard brain imaging template (International
Consortium for Brain Mapping nonlinear average brain template,
ICBM152) (Evans et al., 1994) with automated image registration soft-
ware (Collins et al., 1994). Follow-up scans were then rigidly aligned to
the baseline scan from the same subject (Collins et al., 1994). These
mutually registered scans for each patient were then linearly mapped into
ICBM space by combining the intrapatient transform with the previously
computed transform to stereotaxic space.
Tissue maps
To equalize image intensities across subjects, registered scans were
matched by histogram. A supervised tissue classifier generated detailed
maps of gray matter, white matter, and CSF. Briefly, 120 samples of each
tissue class were interactively tagged to compute the parameters of a
Gaussian mixture distribution that reflects statistical variability in the
intensity of each tissue type (Zijdenbos and Dawant, 1994). A nearest-
neighbor tissue classifier assigned each image voxel to a particular tissue
class (gray, white, or CSF) or to a background class (representing extra-
cerebral voxels in the image). The inter-rater and intra-rater reliability of
this protocol, and its robustness to changes in image acquisition param-
eters, have been described previously (Sowell et al., 1999). Gray and white
matter maps were retained for subsequent analysis.
Three-dimensional cortical maps
A surface model of the cortex was automatically extracted (MacDonald et
al., 2000) for each subject and time point as described in our previous
studies (Thompson et al., 2001c). This software creates a mesh-like sur-
face that is continuously deformed to fit a cortical surface tissue threshold
intensity value from the brain volume. The software was modified to
permit high-resolution extraction of both the lateral and medial hemi-
spheric surfaces, including the cingulate, primary visual cortex, and cor-
pus callosum (Fig. 1). The intensity threshold was defined as the MRI
signal value that best differentiated cortical CSF on the outer surface of
the brain from the underlying cortical gray matter.
Cortical pattern matching
An image analysis technique known as cortical pattern matching was
used to better localize disease effects on cortical anatomy over time and to
increase the power to detect systematic changes. The approach models
and controls for gyral pattern variations across subjects, and it visualizes
average maps of cortical change in a population and encodes its variance
and any group differences.
On the basis of cortical models for each subject at different time points,
a 3D deformation vector field was computed measuring shape change in
the brain surface across the time interval (Thompson et al., 2001c). This
directly accommodates any brain shape changes when comparing corti-
cal gray matter within a subject across time. The deformation reconfig-
ures the earlier cortex into the shape of the later one, matching the entire
gyral patterns and cortical surfaces in the pair of 3D image sets.
Matching cortical anatomy across subjects. A second deformation was
computed that matches gyral patterns across all the subjects in the study
as well as the deformation that matches anatomy over time. This allows
data to be averaged and compared across corresponding cortical regions
[the algorithm for this is described in Thompson et al. (2000a,b)]. As
shown in Figure 1, a large set of 72 sulcal landmarks per brain is used to
constrain the mapping of one cortex onto another. This associates cor-
responding cortical regions across subjects. An image analyst (K.M.H.)
who was blind to subject diagnosis, gender, and age traced each of 30 sulci
in each hemisphere on the surface rendering of each subject’s brain (13
on the medial surface, 17 on the lateral surface). On the lateral brain
surface these included the Sylvian fissure; central, precentral, and post-
central sulci; superior temporal sulcus (STS) main body, STS ascending
branch, and STS posterior branch; primary and secondary intermediate
sulci; and inferior temporal, superior and inferior frontal, intraparietal,
transverse occipital, olfactory, occipitotemporal, and collateral sulci. On
the medial surface these included the callosal sulcus, the inferior callosal
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outline, the paracentral sulcus, anterior and posterior cingulate sulci, the
outer segment of a double parallel cingulate sulcus (where present) (Ono
et al., 1990), the superior and inferior rostral sulci, the parieto-occipital
sulcus, the anterior and posterior calcarine sulci, and the subparietal
sulcus. In addition to contouring the major sulci, a set of six midline
landmark curves bordering the longitudinal fissure was outlined in each
hemisphere to establish hemispheric gyral limits. Spatially registered gray
scale image volumes in coronal, axial, and sagittal planes were available
simultaneously to help disambiguate brain anatomy. Landmarks were
defined according to a detailed anatomical protocol (Steinmetz et al.,
1990; Leonard, 1996; Sowell et al., 2001; Hayashi et al., 2002) based on the
Atlas of the Cerebral Sulci (Ono et al., 1990). This protocol is available on
the internet (Hayashi et al., 2002) and has known inter-rater and intra-
rater reliability, as reported previously (Sowell et al., 2001).
Average cortical model construction. To create an average 3D cortical
model for each group of subjects (e.g., elderly normal or AD), the follow-
ing steps were used (Figs. 1, 2) [for details, see Thompson et al. (2001)].
For each subject, all sulcal/gyral landmarks (Fig. 1b,c) were flattened into
a 2D plane along with the cortical model (Fig. 1e). Technical issues of
minimal distortion and the computation of these flat mappings are ad-
dressed in Thompson et al. (2001c). A color code (Fig. 1f ) retains the
original 3D position of each cortical point as a red, green, and blue color
triplet plotted in the 2D parameter space (Fig. 1f ). Once data are in this
flat space, sulcal features are aligned across subjects with a warping tech-
nique. To illustrate this process, Figure 2a shows part of the flat map of
one subject and its corresponding color code (Fig. 2c). An average set of
sulcal curves, derived from many subjects, is overlaid on the flat map
(Fig. 2a). These maps are warped (Fig. 2b) so that individual sulcal fea-
Figure 1. Creating 3D average cortical models and maps in populations of elderly people and
those with AD: cortical flattening. Using a cortical flattening process (a–f ) and sulcal matching
techniques (Fig. 2), an average model of the cortex (Fig. 2f ) can be built for a group of subjects.
The goal of this process is to allow data (such as gray matter volumes) to be averaged from
corresponding regions of cortex across subjects, reinforcing features that occur consistently.
Briefly, the individual MRI scan (a, gray) is processed to split it up into gray matter ( green),
white matter (red), and cerebrospinal fluid (blue). A 3D cortical surface model ( a) is extracted
from the scan, and the following sulci are traced as 3D curves directly on this surface model. b, c,
Superior and inferior frontal (SFS, IFS), precentral and postcentral ( preCENT, poCENT ), central
(CENT ), intraparietal (IP), superior temporal (STS), Sylvian fissures (SF ), paracentral ( paCENT ),
cingulate (CING) and paracingulate ( paCING), subparietal (subP), callosal (CC), superior and
inferior rostral (SRS, IRS), parieto-occipital (PAOC), and anterior and posterior calcarine (CALCa/
CALCp) sulci. Because the surface is made up of discrete triangular tiles ( d ), a process of geo-
metrical flattening can be applied to lay out the cortical regions, and the sulcal curves that
delimit them, as features in 2D ( e). Information on where these cortical points originally came
from in 3D can still be saved in this 2D image format. Using a color-coding system, cortical point
3D locations (x, y, z) are given unique colors (with intensities of red, green, and blue proportional
to x, y, and z, respectively), and these colors are plotted into the flat map. These color images
represent the cortical shape and are used in Figure 2 to compute information on cortical pattern
differences across subjects and to make an “average shape” cortex for a group of subjects.
Figure 2. Creating 3D average cortical models and maps in elderly populations and those
with AD: sulcal matching. The idea behind sulcal matching is to average cortical data from
corresponding regions across subjects, accommodating sulcal pattern differences across sub-
jects using an elastic warping process. Briefly, the sulcal curves from all the subjects in the study
are flattened, and their shapes are averaged across subjects to make an average set of sulcal
curves ( a). The sulcal pattern of each individual, as seen in the individual’s flattened cortical
map ( a), differs a little from this average set of curves. A 2D elastic deformation can be applied
to an individual’s flat map, which drives its features into exact correspondence with the average
set of sulcal curves ( b). This same deformation can be applied to the color-coded image ( c) that
stores 3D cortical positions from that individual (see Fig. 1 for an explanation). Images such as c
or d can be averaged, pixel by pixel, across all subjects in a group and then decoded to produce
a 3D shape. If this is performed before sulcal matching on images such as c, a smooth cortex
results ( e). It is intriguing that if it is performed on warped color images such as d, a crisp
average cortex results, which reinforces group features in their mean anatomic locations ( f ).
This process can create average cortical models for a group of subjects, but it can also transfer
cortical data (such as gray matter density information) from many subjects onto a common
cortical surface for comparison. In doing so, it accommodates complex differences in cortical
patterning across subjects.
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tures in them are driven into correspondence with the average set of
sulcal curves. Figure 2d shows how this warping process affects a regular
grid ruled over an individual color-coded flat map. The warped color
images (Fig. 2d) from many subjects are averaged together pixel by pixel
and decoded; it can be shown mathematically that this image averaging
creates a crisp average cortical model with gyral features in their mean
anatomic locations (Fig. 2f ) (Thompson and Toga, 1997; Thompson et
al., 2000a,b). The point of this procedure is that the computational
matching of sulci avoids destructive cancellation of features (Fischl et al.,
1999). This cancellation happens when images are directly averaged to-
gether (Fig. 2e). Common features, reinforced in the group average, ap-
pear in their group mean anatomic locations (Fig. 2f ). It is important to
note that local measures of gray matter density (see below) (Fig. 3) may
be convected along with these warps and plotted on the average cortex,
before statistical analysis. Confounding effects of cross-subject anatom-
ical variance are greatly reduced, thereby empowering detection of dis-
ease effects.
Averaging cortical gray matter maps. Given that the deformation maps
associate cortical locations with the same relation to the primary folding
pattern across subjects, a local measurement of gray matter density was
made in each subject and averaged across equivalent cortical locations.
To quantify local gray matter, we used a measure termed gray matter
density, which has been used in many previous studies to compare the
spatial distribution of gray matter across subjects (Wright et al., 1995;
Bullmore et al., 1999; Sowell et al., 1999; Ashburner and Friston, 2000;
Mummery et al., 2000; Rombouts et al., 2000; Baron et al., 2001; Good et
al., 2001; Thompson et al., 2001a,b). This measures the proportion of
gray matter in a small region of fixed radius (15 mm) around each cor-
tical point. Given the large anatomic variability in some cortical regions,
high-dimensional elastic matching of cortical patterns (Thompson et al.,
2000a,b, 2001a) was used to associate measures of gray matter density
from homologous cortical regions first across time and then also across
subjects (Fig. 3). One advantage of cortical matching is that it localizes
deficits relative to gyral landmarks; it also averages data from corre-
sponding gyri, which would be impossible if data were mapped only
linearly into stereotaxic space. Annualized 4D maps of gray matter loss
rates within each subject were elastically realigned for averaging and
comparison across diagnostic groups (Fig. 4).
Mapping gray matter loss
Statistical maps were generated indicating locally the degree to which
gray matter loss rates were statistically linked with diagnosis and cogni-
tive performance (MMSE scores) (Fig. 5). To do this, at each cortical
point, a multiple regression was run to assess whether the gray matter loss
rate at that point depended on the covariate of interest (e.g., test scores,
diagnosis). The p value describing the significance of this linkage was
plotted at each point on the cortex using a color code to produce a
statistical map (Figs. 5, 6, 7).
Permutation testing. Maps identifying these linkages were computed
pointwise across the cortex and assessed statistically by permutation. We
preferred this process over using an analytical null distribution to avoid
assuming that the smoothness tensor of the residuals of the statistical
model were stationary across the cortical surface. The presence of signif-
icant effects in maps of statistics can be tested typically using parametric
inference based on Gaussian random field theory (Friston et al., 1996) or
by nonparametric (e.g., permutation) methods, both of which have been
applied widely in functional (Holmes et al., 1996) and structural brain
imaging (Bullmore et al., 1999; Sowell et al., 1999). We used permutation
here to avoid making assumptions about the spatial covariance of the
residuals (Nichols and Holmes, 2002) and to avoid complex corrections
for data localized on surfaces [for a discussion of this issue, see Thomp-
son et al. (2000a,b)]. Permutation methods, used here, measure the dis-
tribution of features in statistical maps (such as the area with statistics
above a predetermined threshold) that would be observed by accident if
the subjects were randomly assigned to groups. This computed distribu-
tion is then used to compare the features that occurred in the true exper-
iment with those that occurred by accident in the random groupings. A
ratio is computed describing what fraction of the time an effect of similar
or greater magnitude to the real effect occurs in the random assignments.
This is the chance of the observed pattern occurring by accident. This
fraction provides an overall significance value for the map (corrected for
multiple comparisons) (Nichols and Holmes, 2002).
To define a corrected significance value (i.e., an overall p value) for a
Figure 3. Image processing steps applied to individual scans in this study. This flow chart
illustrates the key steps used to process the MRI brain scans in this study. They are illustrated
here on example brain MRI data sets from a healthy control subject (left) and from a patient with
AD (right). First, the MRI images (stage 1) have extracerebral tissues deleted from the scans, and
the individual pixels are classified as gray matter, white matter, or CSF (shown in green, red, and
blue; stage 2). After flattening a 3D geometric model of the cortex (stage 3), features such as the
central sulcus (light blue curve) and cingulate sulcus ( green curve) may be reidentified. An
elastic warp is applied (stage 4 ), thereby moving these features and entire gyral regions ( pink)
into the same reference position in flat space. After aligning sulcal patterns from all individual
subjects, group comparisons can be made at each 2D pixel ( yellow cross-hairs) that effectively
compare gray matter measures across corresponding cortical regions. In this study, the cortical
measure that is compared across groups and over time is the amount of gray matter (stage 2)
lying within 15 mm of each cortical point. The results of these statistical tests can then be
plotted back onto an average 3D cortical model made for the group (Fig. 1), and the findings can
be visualized as a color-coded map (Figs. 4 – 8).
Thompson et al. • Dynamics of Gray Matter Loss in Alzheimer’s Disease J. Neurosci., February 1, 2003 • 23(3):994 –1005 • 997
map, we established a primary threshold of p 0.01 for all significance
maps and measured the total area of the cortex with statistics more sig-
nificant, at a voxel level, than this threshold [as in previous work, for
example, Sowell et al. (2001)]. This threshold ( p  0.01) was chosen a
priori on the basis of our previous work in an independent, cross-
sectional sample (Thompson et al., 2001b) to optimize detection of
broad, diffuse effects. The previous study suggested that large areas of
cortex would be diffusely affected at a voxel-wise significance level stron-
ger than 0.01. The total area of the suprathreshold regions on the surface
was computed. This area measure was used in the permutation tests to
control the number of false positives per map. A total suprathreshold
area statistic was chosen rather than a measure of cluster extent or peak
height (Friston et al., 1996) to sensitize the permutation test to the detec-
tion of subtle but diffuse effects that occur over large (and possibly dis-
connected) regions of cortex. Despite the selection of a low significance
threshold at the voxel level to define clusters, the overall p value for the
map still controls for type I error, because the
threshold to define significant clusters is the
same in the real and in the null simulations
from which the permutation distribution is
drawn. The total area of the average surface
with suprathreshold statistics was used rather
than the number of surface vertices with su-
prathreshold statistics because the total area is
invariant to the sampling density of points on
the surface (so long as the surface is sufficiently
highly sampled).
Control for multiple comparisons. In this type
of statistical map, the number of tests that are
computed is 65,536 per hemisphere, because
this is the number of vertices in the surface
model of each cortical hemisphere. However,
these tests are highly correlated, and the spatial
covariance of their residuals is incorporated
into the null distribution; this controls for the
number of independent tests (Thompson et al.,
2000a,b).
Specification of a region of interest. Because
we expected highly significant effects, we did
not in general restrict the anatomical search
space for the permutation tests, as is common
in functional imaging (Friston et al., 1996).
Permutations were conducted over the entire hemisphere (this results in
conservative control over type I error, because features anywhere on the
cortex enter the null distribution). Left and right hemispheres were as-
sessed separately. In one case, we assessed whether the medial surface was
affected. To do this we created a volume of interest (or search region) that
contained the medial hemispheric surface only, using the surface lines
traced at the interhemispheric margin to define its boundary on the
average surface. Suprathreshold effects in this cortical region were then
assessed to compute a permutation distribution on their total area, and
an overall corrected p value was derived for the medial wall effects.
In each case, the covariate vector was permuted 1 million times on an SGI
RealityMonster supercomputer with 32 internal R10000 processors, and a
null distribution was developed for the area of the average cortex with statis-
tics above a fixed threshold ( p 0.01) in the significance maps. (Post hoc
tests revealed that the corrected p values were robust to differences in the
choice of this primary threshold.) An algorithm was then developed to re-
Figure 5. Mapping links between cognitive performance and changing brain structure. These maps show the significance of the
linkage between gray matter reductions and cognition, as measured by MMSE score. Variations in temporal, parietal, and ulti-
mately frontal ( e) tissue are linked with cognitive status. Less gray matter is strongly correlated with worse cognitive performance,
in all regions with prominent deficits. Linkages are detected most strongly in the left hemisphere medial temporoparietal zones
( d). As expected, no linkages are found with sensorimotor gray matter variation ( b), which was not in significant deficit in late AD.
Figure 4. Average gray matter loss rates in healthy aging and AD. The maps show the average local rates of loss for gray matter, in groups of controls (top, a– d) and patients with AD (bottom,
e– h). Loss rates are1% per year in controls. They are significantly higher in AD and strongest in frontal and temporal regions ( g, h) at this stage of AD (as the MMSE score falls from 18 to 13).
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port the significance probability for each map as a whole (Thompson et
al.,2000a,b, 2001a), so the significance of the loss patterns could be assessed
after the appropriate correction for multiple comparisons. Separate maps
were made to show average rates of loss (Fig. 5) and the significance of this
loss in patients relative to controls (Fig. 6a,b).
Results
Mapping average gray matter deficits in AD
In patients with AD, a highly significant gray matter deficit was ob-
served in a broad anatomical region encompassing bilateral tempo-
ral and parietal cortices (Fig. 6a) (using permutation tests for an
effect of diagnosis; p  0.00495 left hemisphere, p  0.0154 right
hemisphere). The most significant impairments occurred in tempo-
ral and parietal regions (Fig. 6a, red), where deficits exceeded 15%
(Fig. 6c). More intriguing was the anatomical specificity of the loss. A
sharp division occurred in the loss maps (Fig. 6b, blue), with central
and post-central gyri displaying minimal loss compared with the
parietal association cortices immediately posterior to them. Primary
sensory and motor cortices were comparatively spared in the disease
(with a 0–5% deficit on average in the central and postcentral gyri
(Fig. 6b, S/M).
Figure 6e– h (bottom row) shows the average deficit pattern in
AD 1.5 years later, after a rapid decline in MMSE score from
17.7 1.9 to 12.9 2.5 ( p 0.00054). Again, the cortex exhibits
substantial gray matter loss, with deficits intensifying still further
in the most severely affected regions (Fig. 6e,f) (using permuta-
tion tests for an effect of diagnosis; p 0.00027 left hemisphere,
p 0.00056 right hemisphere). Two features are apparent. First,
the frontal cortices, initially only mildly affected (with 6 –10%
loss), are now severely affected (deficits exceeded 15% every-
where) (Fig. 6g), and second, the sensory and motor territory is
still comparatively spared (Fig. 6f, blue), despite the frontal
spread of the deficits.
Dynamic, four-dimensional maps
The time course of these gray matter losses, as they emerge over
a period of cognitive decline lasting 1.5 years, is observed in the
accompanying video sequences (see supplementary data, avail-
able at: http://www.loni.ucla.edu/thompson/AD_4D/dynamic.h-
tml). These 4D data were computed from the maps with a previously
described algorithm (Thompson and Toga, 1997). The transit of
deficits from temporoparietal into frontal cortices is dramatic and so
is the sparing of sensorimotor areas.
Figure 6. Mapping early and late deficits in AD. Deficits occurring during the development of AD are detected by comparing average profiles of gray matter between patients and controls at their
first scan (mean MMSE 18; top) and their follow-up scan 1.5 years later (mean MMSE 13; bottom). The average percentage loss in patients is shown in the right four panels, and the significance
of this loss is shown in the left four panels. Although severe temporal lobe loss ( T ) and parietal loss have already occurred at baseline (top) and subsequently continue (Fig. 4), the frontal deficits
characteristic of late AD are not found until significant cognitive decline has occurred (bottom). A process of fast attrition occurs over the 1.5 years after the baseline scan. Note the relative sparing
of sensorimotor cortices at both disease stages (S/M ). Regionally significant effects are coded red and assessed by permutation, which corrects for multiple comparisons.
Figure 7. Gray matter asymmetry in healthy controls. The asymmetric loss of gray matter in
AD (left hemisphere faster than right) compounds an existing asymmetry in the distribution of
gray matter, observed here in healthy controls (a, b). Here, control subjects show an average
15–20% less gray matter in sensorimotor regions ( a), which is highly significant ( c). These
maps are computed by comparing the average gray matter maps on the left and the right and
taking their ratio (L/R). Comparisons are made after adjusting for both cortical pattern differ-
ences across subjects and gyral pattern asymmetries, using cortical pattern matching (Fig. 2).
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Medial wall effects
Given the interest in early limbic changes in AD, we also mapped
the loss pattern across the medial wall of the brain hemispheres
(Fig. 8). Again, sulcal pattern matching was used to pool infor-
mation from corresponding cortical regions (e.g., cingulate)
across subjects and to create the average maps of gray matter
deficits in AD.
In the left hemisphere, the entire medial cortex was in deficit
at the first scan (Fig. 8b). In the right hemisphere, we found it
intriguing that the anatomy was segregated into three major sys-
tems (Fig. 8a). (1) Greatest impairment (15%) was observed in
the temporal/entorhinal regions and the parietal lobule, and, per-
haps surprisingly, the adjacent occipital/visual cortices; (2) the
cingulate/paralimbic belts (10 to 15% loss) were significantly but
less severely affected (Fig. 8a, yellow); (3) frontal regions, and in
particular orbitofrontal regions (Fig. 8a), were comparatively
spared (0 –5% loss) (Fig. 8a, blue). The left hemisphere was sig-
nificantly more severely impaired than the right ( p  0.029 for
disease-specific asymmetry; corrected p  0.0018 left hemi-
sphere, p 0.014 right hemisphere, for the effect of diagnosis at
the initial scan on the medial wall; permutation tests). Most left
hemisphere regions showed a 15% deficit relative to healthy
controls (Fig. 8b), consistent with our earlier cross-sectional
studies in an independent sample (Thompson et al., 2001b). Both
left and right hemisphere maps suggested that limbic regions are
more intensely impaired than frontal cortices in AD. This re-
mained true even late in the disease when multiple systems are
severely affected (Fig. 8c). After a sharp drop in MMSE score from
18 to 13, most of the cortex was engulfed (Fig. 8, bottom) (cor-
rected p 0.00015 left hemisphere, corrected p 0.00015 right
hemisphere, for the effect of diagnosis on the medial wall; per-
mutation tests). Even then, some cortical regions were mostly
intact (Fig. 8c, blue), specifically in the frontal and sensorimotor
cortices. A frontal band (0 –5% loss) was sharply delimited (Fig.
8c) from the limbic and temporoparietal regions that showed
severest deficits in AD (15% loss). This pattern is consistent
with the hypothesis that AD pathology spreads centrifugally from
limbic/paralimbic to higher-order association cortices (Mesu-
lam, 2000).
Cognitive correlates
It was also important to confirm that these structural differences
were functionally significant. To do this, we tested whether gray
matter differences linked with differences and declines in cogni-
tive performance, as quantified by MMSE scores. MMSE scores
were lower in the AD group than in controls both initially ( p
2.85 107) and after 1.5 years ( p 2.6 108). When rates of
change were considered, MMSE decline over time was highly
significant in AD ( p  0.00054), whereas no changes were de-
tected in the controls (mean change, 0.0; p 0.05).
Highly significant linkages were found relating lower cogni-
tive scores to greater gray matter deficits (Fig. 5). These correla-
tions were observed in all brain regions in which there was signif-
icant loss (Fig. 5a– d), including the temporalparietal and limbic
cortices. Linkages were also found between frontal gray matter
reduction and lower MMSE scores, but only at the later time
point, when frontal gray matter was in significant deficit (Fig. 5e).
As expected, no correlations were found between gray matter
differences in sensory and motor cortices and cognitive perfor-
mance (Fig. 5b, blue, S/M). These maps support the idea that
structure/cognition effects are regionally specific in AD, at least
initially (Fig. 5b). Correlations were strongest in regions with
greatest average loss (left cingulate and left temporal and parietal
cortices) (Fig. 5d). These correlation maps were confirmed to be
significant by permutation ( p  0.0013 left hemisphere, p 
0.0028 right hemisphere, when mean MMSE score was 18, and
p 0.0028 left hemisphere, p 0.0047 right hemisphere, when
mean MMSE score had declined to 13).
Mapping rates of loss
The availability of repeat scans from the same subjects allowed
rates of tissue loss to be computed locally for each subject and
each location on the cortex. These changes are shown as a map
(Fig. 4). This illustrates the group average rate of gray matter loss
across the cortical surface, in patients and controls. Even the
healthy controls showed a trend for diffuse gray matter loss (Fig.
4a– d) ( p  0.08) at an annual rate of 0.91  0.92% per year
overall (left hemisphere 1.16  1.41% per year; right hemisphere
0.67  1.25% per year). However, very few regions exceeded 1%
annual gray matter loss (Fig. 4, top). This approximates the tissue loss
rate seen in normal adolescence (Thompson et al., 2001d). The anat-
omy of the healthy controls therefore remained relatively stable,
whereas their MMSE score remained unchanged at 29.5 0.3.
Patients with AD lost significant gray matter ( p  0.05 for
overall annual loss of gray matter) (Fig. 4e– h) and at a signifi-
cantly more rapid rate than controls ( p 0.042), with a total gray
matter loss rate of 5.03 2.28% per year (left hemisphere 5.43
3.29% per year; right hemisphere 4.64  3.31% per year). Re-
gions with a prominent 4 –5% annual loss included the right
cingulate, temporal, and frontal cortices bilaterally (Fig. 4, bottom
Figure 8. Asymmetric deficits progressing across the medial wall in AD. Medial wall deficits
in AD in the right and left hemispheres (top, a, b). Colors show the average percentage loss of
gray matter relative to the control average. Profound loss engulfs the left medial wall (15%;
b, d). On the right, however, the deficits in temporoparietal and entorhinal territory ( a) spread
forward into the cingulate 1.5 years later ( c), after a five point drop in average MMSE score. Note
the prominent division between limbic and frontal zones, with different degrees of impairment
( c). The corpus callosum is indicated in white; maps of gray matter change are not defined here,
because it is a white matter commissure.
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row). The loss rate patterns were also more spatially diffuse than
the deficit maps at baseline and follow-up (Figs. 5, 6). In sum-
mary, the leading edge of the region with significant deficits
spreads somewhat centrifugally (from medial temporal/limbic to
frontal regions). Nonetheless, the loss rate maps show progres-
sively intensifying deficits at the leading edge (frontal cortex) as
well as in regions that are already severely affected, (e.g., the lat-
eral surfaces of the temporal lobes).
Loss rate asymmetries
In patients with AD, the left hemisphere lost gray matter faster
than the right (0.79% per year faster) ( p 0.04). This is consis-
tent with previous reports of the left hemisphere being more
severely affected in AD, both metabolically and structurally
(Friedland and Luxenberg, 1988; Loewenstein et al., 1989; John-
son et al., 1998; Janke et al., 2001; Thompson et al., 2001b). A
trend for faster gray matter loss in the left hemisphere was also
observed in controls (0.50% per year faster; p 0.057).
Logically, if an asymmetric loss process had already been oc-
curring for many years, one might expect the left hemisphere to
have significantly less gray matter than the right at the baseline
scan, in both patients and controls. This was confirmed to be the
case. Figure 7 shows the average gray matter asymmetry in the
controls, with a prominent sensorimotor region showing 15–
20% less gray matter in the left hemisphere (Fig. 7a) compared
with its counterpart on the right. These maps were created by
subtracting the gray matter map in the left hemisphere from that
on the right, in each individual, before averaging data from cor-
responding cortical regions across subjects. To account for gyral
pattern asymmetries (Geschwind and Levitsky, 1968), this sub-
traction was performed after computing an additional warp in
the cortical parameter space to align each subject’s left and right
gyral patterns. Both controls ( p  0.0069) (Fig. 7c,d) and pa-
tients ( p  0.0091) had significantly less cortical gray matter in
the left hemisphere. In AD, there was also an increase in asym-
metry over time ( p 0.028) in the overall quantity of gray matter
(including deep nuclei as well as cortex). This was not detected in
controls. In AD, the left hemisphere had 2.4% (2.0%) less gray
matter overall than the right at baseline, and 3.5% (2.0%) less
gray matter at follow-up.
This indicates faster left hemisphere cortical degeneration in
AD, at least during the time interval observed in this study. When
the components of this gray matter asymmetry are factored apart,
the loss process in AD therefore occurs first at an asymmetric rate
(left faster than right), and second, on top of a prevailing gray
matter asymmetry (left less than right) observed in AD and even
in healthy elderly subjects.
Whole-brain atrophic rates
Because cortical gray matter maps discriminated patients from
controls so strongly (with p  0.005 initially and p  0.0005 at
follow-up; permutation tests), we wanted to test whether simpler
measures would also reveal disease-related differences or rates of
change. The goal was to compare volumes and maps to see which
detected losses most effectively.
Whole-brain atrophic rates (i.e., the loss rate for total cerebral
volume) were found to discriminate patients and controls. Total
cerebral volume was computed from the cortical models (Fig. 1),
and its annual rate of change was computed for all subjects in the
study. Overall cerebral volume loss rates were significantly faster in
AD than in controls, with a loss rate of 5.22 2.04% per year in AD
( p2.3105), compared with 0.880.15% per year in controls
( p  0.013 for significant loss in controls, p  0.003 for group
difference; both hemispheres pooled). In patients with AD, the left
hemisphere lost volume at 5.86 8.60% per year, compared with
0.99 0.59% in controls ( p 0.019 for significant loss in controls,
p  0.023 for group difference), whereas with AD the right hemi-
sphere lost volume at 4.57 5.61% per year, compared with 0.88
0.46% in controls ( p 0.0083 for significant loss in controls, p
0.0095 for group difference; all tests one-tailed). These disease
effects were found in multiple regressions that controlled for age
and gender (although effects of these covariates were not signifi-
cant; overall multiple r 0.48; p 0.006). A trend for faster left
hemisphere loss also was observed for cerebral volume ( p 
0.055), in line with the significantly faster gray matter loss rate
mapped in the left hemisphere.
To determine whether the cerebral volume loss rate was at-
tributable primarily to gray or white matter degeneration, we also
evaluated white matter loss rates. We did not find a faster white
matter loss rate in AD relative to controls ( p  0.41), although
both groups lost significant white matter over time ( p 0.035).
The white matter loss rate in AD (3.30  2.06% per year; left
hemisphere 3.20  2.91% per year, right hemisphere 3.40 
3.03% per year) was comparable with that in controls (2.72 
1.44% per year; left hemisphere 2.91  2.09% per year, right
hemisphere 2.52  2.07%/year), and no asymmetries were de-
tected ( p 0.1).
Discussion
This study used new longitudinal brain mapping techniques to
chart the transit of structural deficits across the cortex in AD.
When the deficit data are visualized in 4D, a dynamic, spreading
wave of loss is observed. The left hemisphere was engulfed fastest,
with the right after a similar sequence after a time lag. In the right
hemisphere, sharp boundaries appeared in the deficit patterns at
the cingulate/frontal border on the medial wall (Fig. 8c), indicat-
ing differential susceptibility, at least transiently, in mild to mod-
erate AD. Regionally selective atrophy was found in distinct dis-
ease phases, with initial sparing of frontal and then only
sensorimotor cortices. Deficits and rates of change were coupled
with declining cognitive status and quantified by MMSE scores.
As a supplement to clinical measures of disease progression,
which can be notoriously variable (DeCarli, 2000), cortical maps
quantitatively store information on changes expected in AD, of-
fering a standard against which drug effects can be calibrated.
The path of disease progression is appreciated most clearly in
the video sequences (see supplementary data). These suggest a
spatially complex model of different atrophic patterns as AD
progresses. Three main features are observed: (1) the overall def-
icit pattern spreads through the brain in a temporal–frontal–
sensorimotor sequence, with a time lag in the right hemisphere;
(2) the left hemisphere degenerates faster than the right, and this
asymmetric loss rate increases the existing asymmetry in cortical
gray matter (LR) found in healthy elderly subjects; and (3)
some phylogenetically older brain systems are spared late in the
disease (e.g., sensorimotor cortices). The resulting in vivo maps
differentiate AD from normal aging and visualize atrophic pat-
terns associated with specific disease stages.
Pathology
The deficit sequence also matches the trajectory of NFT distribu-
tion observed postmortem in patients with increasing dementia
severity at death (Braak and Braak, 1991, 1997). Consistent with
the deficit maps observed here, NFT accumulation is minimal in
sensory and motor cortices, but it occurs preferentially in ento-
rhinal pyramidal cells, the limbic periallocortex (layers II/IV), the
Thompson et al. • Dynamics of Gray Matter Loss in Alzheimer’s Disease J. Neurosci., February 1, 2003 • 23(3):994 –1005 • 1001
hippocampus/amygdala and subiculum, the basal forebrain cho-
linergic systems, and subsequently, in temporoparietal and fron-
tal association cortices (layers III/V) (Pearson et al., 1985; Arnold
et al., 1991). Neuropathologic studies also reveal that cortical
layers III and V selectively lose large pyramidal neurons in asso-
ciation areas (Brun and Englund, 1981). Immunocytochemical
studies report 11–50% synaptic loss in superior temporal and
inferior parietal cortices in AD (Clinton et al., 1994). A heavy loss
of cholinergic axons occurs, with a variable decrease in cholin-
oreceptive pyramidal neurons (Mesulam, 2000). Gray matter
deficits may indicate a depletion in cholinoreceptive neurons and
perhaps a reduced receptiveness to cholinergic therapy (Hampel
et al., 2002). Gomez-Isla et al. (1997) noted that in AD, both
neuronal loss and NDT density were correlated and increased in
parallel with the duration and severity of illness, whereas the
number of senile plaques and amyloid burden in the superior
temporal sulcus were not related to neuronal loss, number of
NFTs, or duration of disease.
Gray matter atrophy observed with MRI may also be attribut-
able to a combination of processes other than, or in addition to,
neuronal loss, including cell shrinkage, reduced dendritic extent,
and synaptic loss (for review, see McEwen, 1997; Uylings and de
Brabander, 2002). In healthy aging, age-related neuronal loss
does not occur in most regions of the neocortex (Terry et al.,
1987; Morrison and Hof, 1997) and appears specific to the frontal
cortex (de Brabander et al., 1998) and some hippocampal regions
(e.g., CA1 and the subiculum) (Simic et al., 1997). By contrast,
marked neuronal loss occurs in early AD (Gomez-Isla et al.,
1997), with severe early losses in layer II of the entorhinal cortex.
Normal age-related cortical changes may be attributable in part
to cell shrinkage (Shimada, 1999), reduced dendritic length
(Flood et al., 1987; Hanks and Flood, 1991), and changes in per-
fusion, fat and water content, and other chemical constituents
(Weinberger and McClure, 2002). Age-related dendritic reduc-
tion may be region- and lamina-specific (Uylings and Brabander,
2002). Nakamura et al. (1984) found the greatest reductions in
layer V pyramidal basal dendrites with normal aging, and dentate
granule cells also display significantly reduced apical dendritic
length (40% in the dentate gyrus) (Hanks and Flood, 1991). In
summary, changes observed here in normal aging may primarily
reflect cell shrinkage, reductions in dendritic extent, and synaptic
loss; the changes in AD may reflect a combination of these pro-
cesses as well as substantial neuronal loss (Gomez-Isla et al.,
1997).
Metabolism
Metabolic scans in AD, acquired with [ 18F]-fluorodeoxyglucose
positron emission tomography, show a similar deficit pattern.
Decreased metabolic activity is found in temporal and parietal
lobes and in the posterior cingulate cortices (Mazziotta et al.,
1992; Mega et al., 1997). Frontal deficits typically occur later.
These decreases predict cognitive decline rate (on the MMSE)
and also survival (Jagust et al., 1996). A recent review of vascular
and perfusion changes in AD (de la Torre, 2002) noted that cere-
bral hypoperfusion typically predates cortical hypometabolism
in AD. Microvascular changes may therefore contribute to
changing cortical metabolism and neocortical atrophy in AD,
because these changes progress in a similar sequence.
It is interesting that gray matter loss at autopsy is predomi-
nantly cortical in patients with AD who are 80 years of age
(Hubbard and Anderson, 1981). This induces corpus callosum
(Thompson et al., 1998; Hampel et al., 2002) and thalamic atro-
phy (Jernigan et al., 1991), leading to a widespread cortical dis-
connection syndrome. The transition of AD pathology into fron-
tal association cortices suggests a degeneration of synaptically
linked cortical pathways, with a relative sparing of phylogeneti-
cally older, sensorimotor cortices. Occipital regions are also atro-
phic in this study; changes are not always detected in metabolic or
perfusion studies of AD, in which visual cortices often serve as a
control region in PET or single photon emission computed to-
mography imaging studies (Jagust et al., 1996).
Differential susceptibility
The anterior and ventromedial temporal lobes may be especially
susceptible to AD pathology. The vulnerability of neocortical as-
sociation areas may relate to their degree of functional connec-
tivity with limbic structures, in which pathology begins (Arria-
gada, 1992). As noted in a recent physiological model (Mesulam,
2000), increased expression and phosphorylation of tau occurs in
regions with high levels of neuroplasticity (Brion et al., 1994).
This risk factor for NFT formation disrupts the cytoskeleton and
ultimately leads to cell death. The spread of NFT pathology (Hof
and Morrison, 1994; Morrison and Hof, 2002) may originate in
limbic regions because of their high levels of baseline plasticity.
Later cell loss in association areas may result from cortical re-
modeling attributable to impaired input activity in limbic–paral-
imbic neurons that innervate them.
Cortical specificity
In the deficit maps, some barriers to disease progression appear at
architectonic boundaries. The sensorimotor division is clearest
(Figs. 5b, 6b,f); the right cingulate sulcus (Fig. 8c) also delimits
spared frontal from severely affected limbic cortex. These barriers
may be transient, but they suggest that structural deficits may
differ sharply on either side of known architectonic boundaries, a
feature seen in our earlier studies (Thompson et al., 2001b).
Detection power
Practical questions arise in determining the most powerful mea-
sure to discriminate AD from healthy aging and in resolving
treatment effects. Here, gray matter maps, at a single time point,
better discriminated AD ( p 0.00027 at follow-up) than longi-
tudinal loss rates for total cerebral volume ( p 0.003) and rates
of overall gray matter loss ( p  0.04). All of these measures
correlated significantly with cognitive decline. Brain volume
change rates, derived from high-resolution cortical surface mod-
els (Fig. 1), may be more effective at discriminating AD than total
gray matter changes, which may be more susceptible to partial
volume error. Map-based measures showed vastly greater effect
sizes than any measures based on volumes (e.g., p  0.00027 at
follow-up). Increased power may result from restricting the
search space for disease effects to the cortical sheet. Permutation
tests on cluster size (Bullmore et al., 1999; Thompson et al.,
2001c) in the significance maps also sensitize the maps for detect-
ing disease effects.
Advantages of this study
This study builds on previous work on AD progression (DeCarli,
2000; Ashburner et al., 2003). The advantages of this study over
previous work are that advancing deficits are shown in the form
of dynamically changing maps. Cortical pattern matching, a tech-
nique used here, also relates deficits to gyral anatomy (e.g., the
cingulate/frontal division) (Fig. 8c). The image analysis method
involves a high-dimensional registration followed by a test of gray
scale differences and is therefore a hybrid in terms of the contin-
uum between deformation morphometry and voxel-based mor-
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phometry discussed previously in the literature (Ashburner and
Friston, 2001; Bookstein, 2001). As advocated previously (Book-
stein, 2001), high-dimensional warping is used to align structures
across subjects before comparing gray matter differences. This
can increase detection power by reducing the anatomical vari-
ance present in image subtraction methods (Fig. 1). Asymmetries
and group effects can then be mapped using surface-based statis-
tics, after explicitly modeling cortical pattern differences across
hemispheres, subjects, and time (Cannon et al., 2002).
Relation to previous work
Recent techniques to map AD progression use serial image align-
ment (Woods et al., 1993; Fox et al., 1996; Subsol et al., 1997;
Wang et al., 2002), sometimes in conjunction with image defor-
mation techniques (Freeborough and Fox, 1998; Thompson et
al., 2000a,b; Janke et al., 2001; Scahill et al., 2002). These tech-
niques produce an overall measure of change (e.g., brain volume
loss in percentage) (Fox et al., 1999; Wang et al., 2002) or detailed
maps of these changes (Thompson et al., 2000a,b; Janke et al.,
2001). Four-dimensional maps of degenerative rates may also be
derived from a deformation field that elastically transforms a
subject’s anatomy from its earlier configuration to its later shape
(Janke et al., 2001). Using a brain boundary shift integral tech-
nique, Fox et al. (1999, 2000) noted that yearly rates of overall
brain atrophy, based on their measures of total cerebral volume,
were 2.4  1.1% per year in AD and 0.4  0.5% per year in
matched elderly controls (MMSE score 19.6 4.1 and 29.2 1.0
at baseline, for patients and controls, respectively). These mea-
sures are slightly lower than ours (5.22 2.04% per year in AD;
0.88  0.15% per year in controls), although our patients are
slightly more severely impaired (MMSE score falling from 18 to
13 at follow-up). This may support the idea that atrophic rates
accelerate as the disease progresses (Kaye et al., 1999). A limita-
tion of our current study is our use of only two time points per
subject, which forces us to assume linear loss during the interscan
interval. Future studies using multiple time points per patient
(Janke et al., 2001) will reveal whether AD accelerates or
progresses nonlinearly over time.
The profound deficits observed here further support the focus
on temporal lobe as a site of early and progressive change in AD
(Murphy et al., 1993; Kaye et al., 1997; Jack et al., 1998; Laakso et
al., 2000). Jobst et al. (1994) noted faster change rates, even before
symptom development, in normal individuals who went on to
develop mild cognitive impairment. In the future, cortical maps
may help to map preclinical brain change in those at genetic risk
for AD (e.g., ApoE4 carriers) (Small et al., 2000; Reiman et al.,
2001; see also Thompson et al., 2003).
In summary, the dynamic maps presented here suggest that
dynamic structural changes in AD, mapped in living patients, are
congruent with earlier cross-sectional metabolic and pathologic
changes. This sheds light on the complex pattern and timing of
these cortical events. The overall strategy described here also pro-
vides quantitative and visual criteria to assess genetic effects on
brain structure (Thompson et al., 2001a; Thompson and Toga,
2002) and to map drug effects in clinical trials.
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